Navigation Links
Facet Solutions Completes Facet Joint and Disc Replacement Study
Date:10/8/2008

HOPKINTON, Mass., Oct. 8 /PRNewswire/ -- Facet Solutions, Inc. today announced the successful completion of a scientific evaluation for a total joint reconstruction in the lumbar spine by Dr. Vijay Goel's laboratory at the University of Toledo. The study evaluated the combination of Facet Solutions' ACADIA(TM) Facet Replacement System (AFRS(TM)) with a semi-constrained disc replacement device and then, separately, with a polymeric disc replacement device in a finite element model. The results demonstrated restoration of the biomechanics of the native spine. Dr. Goel commented, "The FEA model demonstrates the ability of the ACADIA(TM) technology in combination with different disc replacement technologies to mimic the biomechanics of the intact spine." Marc Peterman, Vice President of R&D for Facet Solutions added, "This study leverages our landmark intellectual property in combining facet replacement with an anterior disc, and it provides further evidence that our anatomic facet design will work with a variety of anterior motion-sparing devices." The details of this study will be presented by Dr. Goel at 11:45am on Tuesday, October 14th at the NASS pre-meeting course in Toronto, Ontario.

Facet Solutions, Inc. has developed the ACADIA(TM) Facet Replacement System (AFRS(TM)) to provide patients with lumbar spinal stenosis and facet degeneration a motion preserving alternative to lumbar spinal fusion. The AFRS(TM) procedure includes replacement of the diseased facet joint with an anatomic implant that restores the natural motion, stability, and balance to the lumbar spine.

*Note: ACADIA(TM) is an investigational device in the United States. It is limited by United States (U.S.) Federal Law for investigational use only.

About Facet Solutions

Facet Solutions, Inc. is a privately held, venture-backed company focused on development and commercialization of surgical devices for the treatment of facet-related spinal disorders. Facet Solutions has received venture capital from its partners De Novo Ventures, Pequot Ventures, and Spray Venture Partners. Facet Solutions is FDA registered and is certified to ISO 13485. The company will be attending the upcoming North American Spine Surgeons Meeting in Toronto, Ontario (booth #1406)


'/>"/>
SOURCE Facet Solutions
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. US Facet Fixation Market to Increase by Over 60% Annually Through 2012
2. Facet Solutions Establishes Corporate Headquarters and Expands Executive Team
3. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
4. Vital Images Releases Next Generation Enterprise-Wide Solutions Featuring Vitrea(R) 4.0 and ViTALConnect(R) 4.1
5. Haemonetics Announces New Subsidiary, Haemonetics Software Solutions
6. BioLife Solutions Expands Scientific Advisory Board
7. Elekta Contract Provides Sisters of Mercy Health System Access to Leading Radiation Therapy Solutions
8. Elekta Displays Complete Volumetric Intensity Modulated Arc Therapy Solutions at ESTRO
9. Total Site Solutions Selected to Provide Construction Management Services for Existing Pharmaceutical and Biotech Customer for Data Center Expansion Project
10. BioLife Solutions CryoStor(TM) Adopted by Tissue Regeneration Therapeutics for Preservation Protocol for New, Non-Embryonic Source of Stem Cells
11. Cooler Solutions and Leading Research Hospital to Design Revolutionary Osteoporosis Diagnosis Device
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2016)... and BEIJING , Nov. 30, 2016 ... provider of genomic services and solutions with cutting edge ... it has completed a USD $75 Million [515 Million ... Ltd.,s CMB International Capital Management ( Shenzhen ... Co., Ltd. ("SDIC Innovation") and Shanghai Sigma Square Investment ...
(Date:11/30/2016)... , Nov. 30, 2016   Merck , ... it has entered into a set of agreements with ... for Merck,s collection of genetic reagents such as CRISPR ... Evotec,s screening expertise offers an accelerated pathway to explore ... starts with the identification of new targets, a process ...
(Date:11/30/2016)... ... November 30, 2016 , ... T3D Therapeutics, Inc., a clinical ... treatment for Alzheimer’s disease (AD), today announced that CEO, John Didsbury, will be ... T3D-959 in mild to moderate Alzheimer’s patients at CTAD 2016. Preliminary results of ...
(Date:11/30/2016)... Toronto, ON (PRWEB) , ... November 30, 2016 ... ... focused on discovery and development of precision treatments for neurodegenerative diseases, today announced ... disease (AD) (announced on November 3, 2016) blocked propagation of toxic, prion-like forms ...
Breaking Biology Technology:
(Date:11/24/2016)... -- Cercacor today introduced Ember TM Sport Premium ... measure hemoglobin, Oxygen Content, Oxygen Saturation, Perfusion Index, ... approximately 30 seconds. Smaller than a smartphone, using only ... key data about their bodies to help monitor these ... Hemoglobin carries oxygen to muscles. When hemoglobin and ...
(Date:11/17/2016)... 17, 2016 Global Market Watch: Primarily ... Banks, Population-Based Banks and Academics) market is to witness a ... Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of ... during the analysis period 2014-2020. North America ... followed by Europe at 9.56% respectively. ...
(Date:11/14/2016)... 14, 2016  xG Technology, Inc. ("xG" or the ... wireless communications for use in challenging operating environments, announced ... 2016. Management will hold a conference call to discuss ... Eastern Time (details below). Key Recent Accomplishments ... million binding agreement to acquire Vislink Communication Systems. The ...
Breaking Biology News(10 mins):